| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a89514464d02d75ef2065a449fb0e617 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2006-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253331a998c366c4a3ce9cb43492f8b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_134c80cb126d4c9de7d17833f18486dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07da0741138df0e3014c2ad3d1f1e2a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0416bfde47f3c907b35b2dab55ebd88e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab6b413944577b02c2bb04d9664b54ce |
| publicationDate |
2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2602224-A1 |
| titleOfInvention |
Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| abstract |
The present invention relates to a new crystalline modification of 6- ( 4-chlorophenyl) -2, 2-dimethyl-7- phenyl-2, S-dihydro-lH-pyrrolizin-S-ylacetic acid which is referred to as polymorph B. It has a peak in the solid state 13C-NMR spectrum (with adamantane as external reference standard; CH group d = 29.45 ppm) in the range from 179.8 to 180.2 ppm and can be processed directly to a pharmaceutical formulation. |
| priorityDate |
2005-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |